Skip to main content

Pathstone Holdings, LLC

Position in NVO — Novo Nordisk A S

CIK 2011612 ENGLEWOOD, NJ

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,206,384
+$5,237,388 QoQ
Shares Held
358,915
+10.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#109
of 1,348 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Pathstone Holdings, LLC holds $630,994,703 across 16 Drug Manufacturers - General names. NVO ranks #8 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
358,915 $17,206,384

All Filings in NVO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,206,384 358,915
2026-03-31 $11,968,996 325,687
2025-12-31 $17,556,295 345,053
2025-09-30 $16,732,786 301,546
2025-06-30 $19,336,572 280,159
2025-03-31 $23,618,487 340,128
2024-12-31 $23,646,983 274,901
2024-09-30 $34,557,566 290,229
2024-06-30 $41,322,516 289,495
2024-03-31 $35,603,779 277,288
2023-12-31 $16,040,853 155,059